Correlation of PET-CT nodal SUVmax with p16...

Abstract

BackgroundThe incidence of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) has been rising in recent years. Given the clinical impact of HPV/p16 positivity in OPSCC, identifying surrogate markers of this disease early in the diagnostic work-up of these patients could improve patient care.MethodsDemographic, pathologic, staging and PET-CT data from patients diagnosed with OPSCC from 2009–2014 were obtained from a …

Authors

Clark J; Jeffery CC; Zhang H; Cooper T; O’Connell DA; Harris J; Seikaly H; Biron VL

Journal

Journal of Otolaryngology, Vol. 44, No. 1,

Publisher

SAGE Publications

Publication Date

1 2015

DOI

10.1186/s40463-015-0091-5

ISSN

1916-0208

Associated Experts

Han Zhang

Associate Professor, Faculty of Health Sciences

Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical sciences 3211 Oncology and Carcinogenesis

Medical Subject Headings (MeSH)

Biomarkers, Tumor Carcinoma, Squamous Cell Cyclin-Dependent Kinase Inhibitor p16 Female Human papillomavirus 16 Humans Immunohistochemistry Male Middle Aged Neoplasm Proteins Neoplasm Staging Oropharyngeal Neoplasms Papillomavirus Infections Positron-Emission Tomography Retrospective Studies Tomography, X-Ray Computed

Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma